OTC · RVRC
Revium Recovery Inc.
$1.43$0.00 (0.0%)
Revium Recovery Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.37% below the high.
Loading market information…
OTC · SGBI · USD
Stock price, earnings
Quote as of Jul 2, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Sangui Biotech International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Sangui Biotech International, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Sangui Biotech International, Inc., through its subsidiary Sangui BioTech GmbH, specializes in creating artificial oxygen carriers derived from hemoglobin. These innovative products are utilized as blood supplements, blood volume replacements, and various related formulations. The company's oxygen carriers are vital for delivering oxygen to humans experiencing acute or chronic oxygen deprivation due to conditions like blocked arteries, anemia, or blood loss, as well as for managing chronic wounds. Their product line also includes nano-formulations designed for skin regeneration, enhancing moisture and elasticity. Furthermore, they provide Chitoskin wound pads to aid in healing and Hemospray, a medical-grade spray specifically formulated for treating persistent wounds. The wound spray products, marketed under the Granulox brand, are primarily distributed in Europe and Mexico, while their cosmetic items are available through an online store. Established in 1995, Sangui Biotech International, Inc. is based in Hamburg, Germany.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.43$0.00 (0.0%)
Revium Recovery Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.37% below the high.
$0.01-$0.00 (-7.41%)
Unrivaled Brands, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.79% below the high.
$0.00$0.00 (0.0%)
Wholehealth Products, Inc.: Healthcare · Medical - Specialties.
$0.00-$0.20 (-99.2%)
Mojave Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.2% below the high.
$0.00-$0.00 (-96.08%)
Sensyne Health plc: Healthcare · Medical - Healthcare Information Services.
$0.00$0.00 (0.0%)
NMC Health plc’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
HTC Purenergy Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.00$0.00 (0.0%)
Ontrak, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.88% below the high.
